PFS
AZN icon

Physicians Financial Services’s AstraZeneca AZN Stock Holding History

Physicians Financial Services’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-350
Closed -$22K – 116
2016
Q4 		$22K Hold
350
– – 0.02% 200
2016
Q3 		$23K Hold
350
– – 0.02% 191
2016
Q2 		$21K Buy
350
+235
+204% +$13.6K 0.02% 198
2016
Q1 		$6K Sell
115
-140
-55% -$8.41K 0.01% 243
2015
Q4 		$17K Buy
+255
New +$16.7K 0.02% 212

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Physicians Financial Services's AZN Position: Q1 2017 in Review

Physicians Financial Services sold out of AstraZeneca (AZN) in Q1 2017, closing a stake of 350 shares — an estimated $22K sold.

Physicians Financial Services first reported a position in AZN in Q4 2015 and held it in 5 quarters. The position peaked at $23K in Q3 2016. 461 funds tracked by Wall St. Rank hold AZN as of Q1 2017.

  • Physicians Financial Services reported no remaining AstraZeneca position as of Q1 2017 after selling out during the quarter.
  • Physicians Financial Services sold 350 AstraZeneca shares in Q1 2017, an estimated $22K.
  • Physicians Financial Services first reported a position in AstraZeneca in Q4 2015 and held it in 5 quarters.
  • Physicians Financial Services's AstraZeneca position peaked at $23K in Q3 2016.
  • 461 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2017.

Based on Physicians Financial Services's 13F filing for Q1 2017, filed 26 Apr 2017.